Discover trends, market shifts, and competitive outlooks for the infectious disease diagnostics testing industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What Is the Current and Projected Market Size of the Infectious Disease Diagnostics Testing Market Through 2034?

The market for infectious disease diagnostic testing has seen rapid expansion in recent years. Its size is set to increase from $38.52 billion in 2024 to $42.56 billion in 2025, with a compound annual growth rate (CAGR) of 10.5%. Factors contributing to this growth during the historical period include the occurrence of disease outbreaks like SARS, Ebola and Zika, heightened understanding amongst healthcare experts and the wider public of the need for early identification and thwarting of infectious diseases, the rise in government subsidised programmes devoted to disease surveillance, control and prevention, intensified international travel and trade which contribute to the spread of infectious ailments, as well as augmented expenditure on healthcare, most notably in developing economies.

Expectations are high for the infectious disease diagnostics testing market to experience rapid expansion in the coming years, with projections estimating it will reach a value of $62.58 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 10.1%. Factors contributing to this expected growth throughout the forecast period include the constant emergence of new pathogens like new influenza strains or COVID-19, a move towards personalized medicine and targeted treatments, an increasing demand for quick, on-site testing options, a heightened focus on epidemiological surveillance and early detection systems, and a surge in research and development activities aimed at creating innovative diagnostic technologies and biomarkers. Key trends predicted for the forecast period involve the miniaturization and portability of diagnostic devices, the use of multiplex assays able to detect multiple pathogens at once, the incorporation of digital health solutions like mobile apps and telemedicine platforms, the use of next-generation sequencing (NGS) technologies in infectious disease diagnostics, improvements in biosensor technologies for the fast and sensitive detection of infectious agents, and the incorporation of AI and machine learning algorithms into diagnostic platforms.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15831&type=smp

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Infectious Disease Diagnostics Testing Market?

The expected surge in respiratory infections is anticipated to drive the growth of the infectious disease diagnostic testing market. Respiratory infections, which impact the respiratory system including the nose, throat, airways, and lungs, are increasing due to factors such as viral and bacterial transmission from close contact with infected individuals, poor hygiene habits, congested living conditions, and seasonal changes in weather patterns. It’s critical to use infectious disease diagnostic testing to diagnose and treat these infections, as it can accurately identify pathogens such as bacteria and viruses in patient samples. To illustrate, the Canadian Institute for Health Information, a non-profit organization based in Canada, reported in February 2024 that hospitalizations due to acute upper respiratory infections rose by 32% from 2,114 cases in 2022 to 2,797 cases in 2023. Hence, the surging respiratory infections are fueling the infectious disease diagnostic testing market’s growth.

Which Segments in the Infectious Disease Diagnostics Testing Offer the Most Growth?

The infectious disease diagnostics testing market covered in this report is segmented –

1) By Type: Molecular Diagnostic Test, Point Of Care Tests (POCT) Infectious Disease Diagnostics Test

2) By Application: Respiratory, Human Immunodeficiency Virus (HIV), Healthcare-Associated Infections (HAIs), Sexual Health, Tropical Diseases, Liver

3) By End-User: Diagnostic Laboratories, Hospitals And Clinics, Academic Research Institutes, Other End-Users

Subsegments:

1) By Molecular Diagnostic Test: Polymerase Chain Reaction (PCR) Tests, Nucleic Acid Amplification Tests (NAATs), Next-Generation Sequencing (NGS), Microarray-Based Tests

2) By Point Of Care Tests (POCT) Infectious Disease Diagnostics Test: Lateral Flow Assays, Rapid Antigen Tests, Immunoassays, Portable PCR

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=15831&type=smp

Which Areas Are Leading Regions in the Infectious Disease Diagnostics Testing Market Expansion Across the Globe?

North America was the largest region in the infectious disease diagnostics testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infectious disease diagnostics testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Key Market Trends and Innovations Are Shaping the Future of the Infectious Disease Diagnostics Testing Industry?

The infectious disease diagnostic testing market is witnessing a major shift as key players are introducing innovative technologies such as molecular diagnostics platforms to maintain their market standing. Such platforms are advanced systems that identify and scrutinize the nucleic acids, DNA or RNA, from biological specimens for diagnostic usage. For instance, in May 2022, BD COR System, an entirely automated, high-volume infectious disease molecular diagnostics platform, was introduced by Becton Dickinson, a US-based medical technology corporation. This platform has the capability to process the complete molecular lab process from sample analyses to diagnostics result, thus eliminating manual specimen classification and allowing lab technicians to concentrate on more important tasks. Remarkably, the system can process up to 1,700 specimens and deliver results in less than 24 hours. This system also offers high-volume processing and advanced genotyping for diseases like HPV and STIs.

View the full report here:

https://www.thebusinessresearchcompany.com/report/infectious-disease-diagnostics-testing-global-market-report

What Are the Key Elements That Define the Infectious Disease Diagnostics Testing Market?

Infectious disease diagnostics testing refers to the process of identifying the presence of pathogens, such as bacteria, viruses, fungi, or parasites, in a patient’s body. These tests are crucial for diagnosing infectious diseases and guiding appropriate treatment decisions. Infectious disease diagnostics testing plays a vital role in controlling the spread of infectious diseases, guiding treatment decisions, and monitoring outbreaks.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15831

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model